BREXTEM S- niacinamide liquid
Brexogen Inc.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
----------
For external use only
1.Discontinue use if signs of irritation or rashes appear. If symptoms get worse, consult with a dermatologist. 1) In case of swelling, itching, or other side effects while or after using this product.
2. Do not apply to open wounds.
3. Avoid contact with eyes.
4. Precautions for storage and handling.
5. Keep in the refrigerator at 2-6℃.
6. Keep out of reach of children
7. Avoid direct sunlight
■ Gently mix with BREXTEM powder to dissolve the mixture. Take proper amount and gently apply onto the skin.
Powder: Mannitol, Human Cord Blood Induced Pluripotent Cell Exosomes
Solution: Water, Dipropylene Glycol, Glycerin, Butylene Glycol, Allantoin, Myrothamnus Flabellifolia Callus CultureExtract, Propolis Extract, 1,2-Hexandiol, Caprylyl Glycol, Adenosine, Copper Tripeptide-1, Acetyl Hexapeptide-8, Palmitoyl Pentapeptide-4, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-1, Tripeptide-29, Diospyros Kaki Fruit Extract, Camellia Japonica Leaf Extract, Ceratonia Siliqua (Carob) Fruit Extract, Rubus Idaeus (Raspberry) Fruit Extract, Polyglyceryl-10 Laurate, Ethylhexylglycerin
BREXTEM S
niacinamide liquid |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Brexogen Inc. (695721823) |
Registrant - Brexogen Inc. (695721823) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Enveco Cosmetic Co., Ltd. | 689061861 | manufacture(83630-010) |